CVS Health promoted Dr. Sreekanth Chaguturu to lead its healthcare delivery business a year after the company spent $20 ...

CVS Health has added four new board members, including the CEO of a hedge fund that has been critical of the struggling ...

CVS Health said four new members will be added to its board from the hedge fund Glenview Capital, which had been pushing for ...

Analyst Elizabeth Anderson CFA of Evercore ISI maintained a Buy rating on CVS Health (CVS – Research Report), retaining the price target of $75.00. Don't Miss our Black Friday Offers: Elizabeth ...

CVS Health is the first company to earn a Health Equity Accreditation from URAC. The independent nonprofit accrediting ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks CVS Health ( (CVS) ) has issued an announcement.

Mike Pykosz is no longer president of healthcare delivery at CVS Health. Pykosz, who co-founded Oak Street Health and was CEO ...

CVS Health said on Monday it named four new members to its board of directors as part of a deal with activist investor Glenview Capital as the healthcare company continues to fight its way out of its ...

CVS Health said on Monday it named four new members to its board of directors as part of a deal with activist investor ...

CVS Health Corporation (NYSE: CVS) shares are trading higher Monday after the company announced the addition of four new directors to its board. Here's what you need to know.

CVS Health has named Sreekanth Chaguturu, MD, president of healthcare delivery. Dr. Chaguturu will succeed Mike Pykosz, who decided to exit the company, according to a Nov. 19 news release. In his new ...

The original August lawsuit accused the World Federation of Advertisers, CVS Health, candy maker Mars and Danish renewable ...